A phase Ib study to assess the safety of the human papillomavirus DNA vaccine (AMV002) in combination with durvalumab for HPV-associated oropharyngeal squamous cell carcinoma by Rahul Ladwa, Rahul Ladwa, Janin Chandra, Wai-Ping Woo, Wai-Ping Woo, Neil Finlayson, Howard Liu, Howard Liu, Margaret McGrath, Adrienne See, Brett G. Hughes, Brett G. Hughes, Caroline L. Cooper, Caroline L. Cooper, Jim E. Jackson, Marcin Dzienis, Yan Xu, Yan Xu, Benedict Panizza, Benedict Panizza, Ian Frazer, Ian Frazer, Sandro V. Porceddu, Sandro V. Porceddu

Get full text